Colin Walsh
Direttore/Membro del Consiglio presso Ceptur Therapeutics, Inc.
Profilo
Colin Walsh is currently a Director at Ceptur Therapeutics, Inc. He is also a Board Member at Element Science, Inc. since 2019 and a Board Member at Korro Bio, Inc. since 2020.
Previously, he served as an Independent Director at Elevation Oncology, Inc. from 2019 to 2023.
He was also a Vice President at NanoDimension, Inc. and a Partner at Qiming US Ventures Management, LLC from 2020 to 2023.
Dr. Walsh holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of Massachusetts Amherst.
Posizioni attive di Colin Walsh
| Società | Posizione | Inizio |
|---|---|---|
Ceptur Therapeutics, Inc.
 Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | Direttore/Membro del Consiglio | - |
Korro Bio, Inc.
 Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 01/08/2020 |
Element Science, Inc.
 Element Science, Inc. Electronic Equipment/InstrumentsElectronic Technology Element Science, Inc. operates as a medical device and digital health company. It develops a wearable platform solution with proprietary technology in wearable patches, electrical design, machine learning algorithms and digital solutions. The company was founded by Uday N. Kumar in 2011 and is headquartered in San Francisco, CA. | Direttore/Membro del Consiglio | 01/08/2019 |
Precedenti posizioni note di Colin Walsh
| Società | Posizione | Fine |
|---|---|---|
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Investitore di Private Equity | 31/10/2023 |
| ELEVATION ONCOLOGY, INC. | Direttore/Membro del Consiglio | 21/09/2023 |
| NanoDimension, Inc. | Corporate Officer/Principal | - |
Formazione di Colin Walsh
| University of Massachusetts Amherst | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ELEVATION ONCOLOGY, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Ceptur Therapeutics, Inc.
Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | Health Technology |
| NanoDimension, Inc. | Finance |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Health Technology |
Element Science, Inc.
Element Science, Inc. Electronic Equipment/InstrumentsElectronic Technology Element Science, Inc. operates as a medical device and digital health company. It develops a wearable platform solution with proprietary technology in wearable patches, electrical design, machine learning algorithms and digital solutions. The company was founded by Uday N. Kumar in 2011 and is headquartered in San Francisco, CA. | Electronic Technology |
- Borsa valori
- Insiders
- Colin Walsh
